Cargando…

Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’

Detalles Bibliográficos
Autores principales: Sahbudak Bal, Zumrut, Zeytinoglu, Aysin, Ozkinay, Ferda, Kurugol, Zafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359395/
https://www.ncbi.nlm.nih.gov/pubmed/35576120
http://dx.doi.org/10.1080/21645515.2022.2073760
_version_ 1784764132635967488
author Sahbudak Bal, Zumrut
Zeytinoglu, Aysin
Ozkinay, Ferda
Kurugol, Zafer
author_facet Sahbudak Bal, Zumrut
Zeytinoglu, Aysin
Ozkinay, Ferda
Kurugol, Zafer
author_sort Sahbudak Bal, Zumrut
collection PubMed
description
format Online
Article
Text
id pubmed-9359395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-93593952022-08-10 Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’ Sahbudak Bal, Zumrut Zeytinoglu, Aysin Ozkinay, Ferda Kurugol, Zafer Hum Vaccin Immunother Licensed Vaccines – Letters Taylor & Francis 2022-05-16 /pmc/articles/PMC9359395/ /pubmed/35576120 http://dx.doi.org/10.1080/21645515.2022.2073760 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Licensed Vaccines – Letters
Sahbudak Bal, Zumrut
Zeytinoglu, Aysin
Ozkinay, Ferda
Kurugol, Zafer
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title_full Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title_fullStr Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title_full_unstemmed Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title_short Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
title_sort response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered turkish children; mav/06 and voka’
topic Licensed Vaccines – Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359395/
https://www.ncbi.nlm.nih.gov/pubmed/35576120
http://dx.doi.org/10.1080/21645515.2022.2073760
work_keys_str_mv AT sahbudakbalzumrut responsetoalettertotheeditorregardingthecomparisonofseroconversionratesamongdifferentvaricellavaccinesadministeredturkishchildrenmav06andvoka
AT zeytinogluaysin responsetoalettertotheeditorregardingthecomparisonofseroconversionratesamongdifferentvaricellavaccinesadministeredturkishchildrenmav06andvoka
AT ozkinayferda responsetoalettertotheeditorregardingthecomparisonofseroconversionratesamongdifferentvaricellavaccinesadministeredturkishchildrenmav06andvoka
AT kurugolzafer responsetoalettertotheeditorregardingthecomparisonofseroconversionratesamongdifferentvaricellavaccinesadministeredturkishchildrenmav06andvoka